TLR2 and chronic kidney disease: The high SDMA content makes CKD-HDL activate Toll-like receptor-2 (TLR-2) that inhibits the phosphorylation of Akt and eNOS, and hence NO production, but promotes activation of JNK and thereby NADPH oxidase-dependent superoxide production [112].